Literature DB >> 15704703

Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and use of the health services.

Victoria M Grace1, Krina T Zondervan.   

Abstract

UNLABELLED: Chronic pelvic pain (CPP) in women is often debilitating and isolating. Problems with diagnosis continue to make CPP one of the most perplexing conditions in gynaecology, and one of the most difficult to treat.
OBJECTIVES: This paper reports the findings of a population-based study in New Zealand in 2001 designed to investigate the prevalence of chronic pelvic pain in women between the ages of 18 and 50. Chronic pelvic pain was defined as pain that is neither associated with the menstrual cycle nor sexual activity. The prevalence of dysmenorrhoea and dyspareunia was also sought. It further aimed to examine pain severity, diagnoses, and the use of the health services as these facets of CPP affect different groups of women within New Zealand.
METHODS: A random sample of 2261 was generated from the New Zealand Electoral Roll, and a postal questionnaire was administered during 2001. The response rate was 66% (adjusted for non-receivers), giving a study group of 1,160 respondents.
RESULTS: The three-month CPP prevalence rate was 25.4% (95% CI 22.8-27.9). Half of those women reporting CPP (47.7%) remained undiagnosed. The three-month prevalence of dysmenorrhoea was 55.2%, and dyspareunia 19.7%. Recent or past consulters of health services for CPP contained a higher proportion of women with a high pain burden than those not consulting health services. Only one-third of New Zealand women (34%) reported no form of chronic pelvic pain (i.e. no CPP, dysmenorrhoea or dyspareunia). These prevalence rates indicate that CPP should receive greater public education and clinical attention.

Entities:  

Mesh:

Year:  2004        PMID: 15704703     DOI: 10.1111/j.1467-842x.2004.tb00446.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  30 in total

Review 1.  Psychological factors in chronic pelvic pain in women: relevance and application of the fear-avoidance model of pain.

Authors:  Meryl J Alappattu; Mark D Bishop
Journal:  Phys Ther       Date:  2011-08-11

Review 2.  A Narrative Review of Musculoskeletal Impairments Associated With Nonspecific Chronic Pelvic Pain.

Authors:  Marcie Harris-Hayes; Theresa Spitznagle; Daniel Probst; Stefanie N Foster; Heidi Prather
Journal:  PM R       Date:  2019-07-25       Impact factor: 2.298

3.  Anatomical basis of digital rectal examination.

Authors:  E Joguet; R Robert; J J Labat; T Riant; M Guérineau; O Hamel; J M Louppe
Journal:  Surg Radiol Anat       Date:  2011-06-04       Impact factor: 1.246

4.  Multimodal nociceptive mechanisms underlying chronic pelvic pain.

Authors:  Kevin M Hellman; Insiyyah Y Patanwala; Kristen E Pozolo; Frank F Tu
Journal:  Am J Obstet Gynecol       Date:  2015-08-20       Impact factor: 8.661

Review 5.  Interventional therapies for controlling pelvic pain: what is the evidence?

Authors:  Isabel C Green; Sarah L Cohen; Dayna Finkenzeller; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-02

6.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

Review 7.  [Chronic pollakiuria: cystectomy or psychotherapy].

Authors:  A Kuffel; K P Kapitza; B Löwe; E Eichelberg; A Gumz
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

8.  [Psychosomatic aspects of chronic pelvic pain syndrome. Psychometric results from the pilot phase of an interdisciplinary outpatient clinic].

Authors:  C A Brünahl; B Riegel; J Höink; A Kutup; E Eichelberg; B Löwe
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

9.  Management of endometriosis in general practice: the pathway to diagnosis.

Authors:  Zoë Pugsley; Karen Ballard
Journal:  Br J Gen Pract       Date:  2007-06       Impact factor: 5.386

Review 10.  Nonsteroidal antiinflammatory drug resistance in dysmenorrhea: epidemiology, causes, and treatment.

Authors:  Folabomi A Oladosu; Frank F Tu; Kevin M Hellman
Journal:  Am J Obstet Gynecol       Date:  2017-09-06       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.